Analysis of the correlation between JAK inhibitors and thromboembolic events:a real-world study based on data from the FDA’s adverse event reporting system

LIU Jie, TANG Zheng-bo

Chinese Journal of Hospital Pharmacy ›› 2022, Vol. 42 ›› Issue (10) : 1046-1050.

PDF(1220 KB)
PDF(1220 KB)
Chinese Journal of Hospital Pharmacy ›› 2022, Vol. 42 ›› Issue (10) : 1046-1050. DOI: 10.13286/j.1001-5213.2022.10.13

Analysis of the correlation between JAK inhibitors and thromboembolic events:a real-world study based on data from the FDA’s adverse event reporting system

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 42(10): 1046-1050 https://doi.org/10.13286/j.1001-5213.2022.10.13

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1220 KB)

Accesses

Citation

Detail

Sections
Recommended

/